Therasse and colleagues: RECIST guidelines for solid tumours

What changed

Standardized one-dimensional lesion measurement and categorical solid-tumour treatment-response assessment in RECIST 1.0.

Scientific scope

The record is the exact eleven-author RECIST 1.0 paper. It is a response-assessment standard rather than evidence that a therapy benefits patients, and later RECIST revisions and immune-response criteria remain distinct.

Evidence

The linked sources identify this contribution and its scope. WRS has not independently reconstructed the scientific claims. The record is the exact eleven-author RECIST 1.0 paper. It is a response-assessment standard rather than evidence that a therapy benefits patients, and later RECIST revisions and immune-response criteria remain distinct.

Contributors

• The named authors listed in the linked research record · SCIENCE: Complete source byline retained in the research record; this collective display does not merge person identities or measure labor shares.

• Therasse and colleagues: RECIST guidelines for solid tumours

Provisional WRS assessment, edition 2026-10-16.1. Independent expert calibration is pending. This grade does not certify correctness or assign ownership.

Full scientific record · Browse contribution grades · Request a correction